Zobrazeno 1 - 10
of 53
pro vyhledávání: '"V.S. Kavadi"'
Autor:
D. Michaelson, J.J. Dignam, D.A. Hamstra, F. Bachand, V. Master, D.W. Bruner, M. Torres, P.J. Saylor, R.E. Wallace, N. Vapiwala, J.A. Efstathiou, M. Roach, S.A. Rosenthal, A. Raben, S.C. Morgan, V.S. Kavadi, D.E. Spratt, J.M. Michalski, J. Rodgers, H.M. Sandler
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:S67-S68
Autor:
D.W. Bruner, S. Pugh, D. Michaelson, D.A. Hamstra, F. Bachand, V. Master, M. Torres, I.D. Kaplan, S.A. Rosenthal, M. Roach, A. Raben, J.M. Michalski, V.S. Kavadi, M. Ferguson, S.C. Morgan, D.P. D'Souza, L. DeMora, H.M. Sandler, B. Movsas
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:e214
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Melody A. Cobleigh, Stewart J. Anderson, Norman Wolmark, Douglas W. Arthur, Allison Zibelli, J. Lyons, Marianne K. Melnik, Melissa S. Dillmon, Matthew L. Hill, David S. Parda, Eleftherios P. Mamounas, Thomas B. Julian, Samantha A. Seaward, Dennis L. Carter, V.S. Kavadi, Lavanya Tiriveedhi, Gustav Magrinat, Sushil Beriwal, Rachel Rabinovitch, Kalliopi P. Siziopikou
Publikováno v:
J Clin Oncol
PURPOSE Preclinical studies report that trastuzumab (T) can boost radiotherapy (RT) effectiveness. The primary aim of the B-43 trial was to assess the efficacy of RT alone vs concurrent RT plus T in preventing recurrence of ipsilateral breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff244299bf20a477f0d82018364ef159
https://europepmc.org/articles/PMC8462554/
https://europepmc.org/articles/PMC8462554/
Autor:
Walter J. Curran, Joanne Meng, Christopher Koprowski, Jeffrey D. Bradley, Steven E. Schild, Raymond B. Wynn, Gregory A. Masters, Michael R. Olson, Anthony M. Magliocco, Puneeth Iyengar, Jeffrey A. Bogart, Clifford G. Robinson, Chen Hu, Kenneth M. Forster, Rebecca Paulus, Ritsuko Komaki, Hak Choy, V.S. Kavadi, Samir Narayan, George R. Blumenschein
Publikováno v:
J Clin Oncol
PURPOSE RTOG 0617 compared standard-dose (SD; 60 Gy) versus high-dose (HD; 74 Gy) radiation with concurrent chemotherapy and determined the efficacy of cetuximab for stage III non–small-cell lung cancer (NSCLC). METHODS The study used a 2 × 2 fact
Autor:
Jose G. Bazan, Tarek Hijal, Julia White, James M. Galvin, Frank A. Vicini, Marc T. Fields, Michael Lock, Gary M. Freedman, Bethany Anderson, Susan McNulty, Janice A. Lyons, Douglas W. Arthur, Adam Currey, Ying Xiao, X. Allen Li, Jennifer Moughan, Kristine E. Kokeny, V.S. Kavadi, Melissa Mitchell, Sally B. Cheston
Publikováno v:
Pract Radiat Oncol
Purpose To investigate patterns of failure in institutional credentialing submissions to NRG/RTOG 1005 with the aim of improving the quality and consistency for future breast cancer protocols. Methods and Materials NRG/RTOG 1005 allowed the submissio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b8e7082696233ff026f2e15d83c6c0
https://europepmc.org/articles/PMC7255922/
https://europepmc.org/articles/PMC7255922/
Autor:
Mohamed A. Elshaikh, Benjamin Movsas, Fabio Cury, J.M. Michalski, V.S. Kavadi, Theodore Karrison, Bruce Hershatter, Alvaro Martinez, Deborah Citrin, Michael Lock, G. Morton, Deborah Watkins Bruner, Jason A. Efstathiou, H.M. Sandler, Adam Raben, Adam Currey, Daniel J. Krauss, Di Yan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S1
Purpose/Objective(s) Androgen suppression can improve outcomes when added to radiotherapy (RT) for intermediate risk prostate cancer, but no study to date has reported its utility in the context of contemporary, dose-escalated RT. Herein, the clinica
Autor:
Deborah Watkins Bruner, Elizabeth Gore, Mohamed A. Elshaikh, Alvaro Martinez, Daniel J. Krauss, H.M. Sandler, Vikram Velker, Benjamin Movsas, Di Yan, C.A. Schulz, Bruce Hershatter, Adam C. Olson, Theodore Karrison, G. Morton, Deborah Citrin, J. Rodgers, G.S. Gustafson, J.M. Michalski, Rodney J. Ellis, V.S. Kavadi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S3
PURPOSE/OBJECTIVE(S) To report the PROs of a phase III randomized trial evaluating TAS combined with dose-escalated RT for patients with intermediate risk prostate cancer. MATERIALS/METHODS Eligible patients had intermediate risk prostate cancer defi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elizabeth Gore, Feng Ming Kong, J. Rothman, Samir Narayan, Jeffrey A. Bogart, Weili Wang, J. Welsh, Julie A. Bradley, V.S. Kavadi, Robert MacRae, R. Gaur, G.M. Cannon, C.D. Koprowski, I.Y. Garces, B. Lu, Cliff G. Robinson, JianYue Jin, Chen Hu, Mitchell Machtay
Publikováno v:
Journal of Thoracic Oncology. 16:S181